Annual Total Liabilities
$1.36 M
-$675.50 K-33.21%
30 June 2024
Summary:
NanoViricides annual total liabilities is currently $1.36 million, with the most recent change of -$675.50 thousand (-33.21%) on 30 June 2024. During the last 3 years, it has risen by +$1.01 million (+287.01%). NNVC annual total liabilities is now -93.37% below its all-time high of $20.49 million, reached on 30 June 2014.NNVC Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$1.63 M
+$273.90 K+20.16%
01 September 2024
Summary:
NanoViricides quarterly total liabilities is currently $1.63 million, with the most recent change of +$273.90 thousand (+20.16%) on 01 September 2024. Over the past year, it has dropped by -$815.60 thousand (-33.31%). NNVC quarterly total liabilities is now -92.03% below its all-time high of $20.49 million, reached on 30 June 2014.NNVC Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NNVC Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -33.2% | -33.3% |
| 3 y3 years | +287.0% | +87.8% |
| 5 y5 years | -52.3% | -38.5% |
NNVC Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -33.2% | +287.0% | -33.3% | +374.2% |
| 5 y | 5 years | -52.3% | +287.0% | -58.1% | +381.2% |
| alltime | all time | -93.4% | +1958.8% | -92.0% | +381.2% |
NanoViricides Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.63 M(+20.2%) |
| June 2024 | $1.36 M(-33.2%) | $1.36 M(+67.1%) |
| Mar 2024 | - | $813.30 K(-14.5%) |
| Dec 2023 | - | $951.10 K(-61.2%) |
| Sept 2023 | - | $2.45 M(+20.4%) |
| June 2023 | $2.03 M(+392.8%) | $2.03 M(+483.4%) |
| Mar 2023 | - | $348.70 K(-24.9%) |
| Dec 2022 | - | $464.60 K(-10.4%) |
| Sept 2022 | - | $518.40 K(+25.6%) |
| June 2022 | $412.80 K(+17.6%) | $412.80 K(+6.7%) |
| Mar 2022 | - | $386.70 K(+12.3%) |
| Dec 2021 | - | $344.30 K(-60.4%) |
| Sept 2021 | - | $869.50 K(+147.7%) |
| June 2021 | $351.10 K(-83.7%) | $351.10 K(-59.7%) |
| Mar 2021 | - | $871.30 K(+156.8%) |
| Dec 2020 | - | $339.30 K(-81.8%) |
| Sept 2020 | - | $1.87 M(-13.5%) |
| June 2020 | $2.16 M(-24.3%) | $2.16 M(-2.6%) |
| Mar 2020 | - | $2.21 M(-43.2%) |
| Dec 2019 | - | $3.90 M(+46.7%) |
| Sept 2019 | - | $2.66 M(-6.7%) |
| June 2019 | $2.85 M(+223.0%) | $2.85 M(+6.4%) |
| Mar 2019 | - | $2.68 M(+130.1%) |
| Dec 2018 | - | $1.16 M(-16.4%) |
| Sept 2018 | - | $1.39 M(+57.9%) |
| June 2018 | $881.90 K(-86.8%) | $881.90 K(-72.4%) |
| Mar 2018 | - | $3.19 M(-59.1%) |
| Dec 2017 | - | $7.81 M(+15.7%) |
| Sept 2017 | - | $6.75 M(+1.0%) |
| June 2017 | $6.68 M(-50.8%) | $6.68 M(+8.2%) |
| Mar 2017 | - | $6.17 M(-49.5%) |
| Dec 2016 | - | $12.22 M(-12.7%) |
| Sept 2016 | - | $14.00 M(+3.0%) |
| June 2016 | $13.59 M(+9.5%) | $13.59 M(-5.2%) |
| Mar 2016 | - | $14.34 M(+15.0%) |
| Dec 2015 | - | $12.46 M(+7.6%) |
| Sept 2015 | - | $11.59 M(-6.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2015 | $12.40 M(-39.5%) | $12.40 M(-9.8%) |
| Mar 2015 | - | $13.74 M(-19.6%) |
| Dec 2014 | - | $17.10 M(+40.2%) |
| Sept 2014 | - | $12.19 M(-40.5%) |
| June 2014 | $20.49 M(+144.0%) | $20.49 M(+129.7%) |
| Mar 2014 | - | $8.92 M(-29.6%) |
| Dec 2013 | - | $12.68 M(-5.1%) |
| Sept 2013 | - | $13.36 M(+59.1%) |
| June 2013 | $8.40 M(+371.9%) | $8.40 M(+8.3%) |
| Mar 2013 | - | $7.75 M(+454.8%) |
| Dec 2012 | - | $1.40 M(-10.3%) |
| Sept 2012 | - | $1.56 M(-12.5%) |
| June 2012 | $1.78 M(+203.1%) | $1.78 M(+121.3%) |
| Mar 2012 | - | $804.10 K(-31.4%) |
| Dec 2011 | - | $1.17 M(+18.3%) |
| Sept 2011 | - | $991.20 K(+68.8%) |
| June 2011 | $587.20 K(-76.3%) | $587.20 K(-27.5%) |
| Mar 2011 | - | $809.70 K(-54.7%) |
| Dec 2010 | - | $1.79 M(+2.5%) |
| Sept 2010 | - | $1.75 M(-29.4%) |
| June 2010 | $2.47 M(+379.7%) | $2.47 M(+158.0%) |
| Mar 2010 | - | $958.70 K(-24.0%) |
| Dec 2009 | - | $1.26 M(+126.4%) |
| Sept 2009 | - | $557.10 K(+8.0%) |
| June 2009 | $515.70 K(-49.7%) | $515.70 K(-23.7%) |
| Mar 2009 | - | $675.70 K(+21.0%) |
| Dec 2008 | - | $558.60 K(-44.2%) |
| Sept 2008 | - | $1.00 M(-2.2%) |
| June 2008 | $1.02 M(+20.5%) | $1.02 M(+99.6%) |
| Mar 2008 | - | $513.20 K(+33.1%) |
| Dec 2007 | - | $385.60 K(-49.3%) |
| Sept 2007 | - | $760.90 K(-10.5%) |
| June 2007 | $849.90 K(-43.0%) | $849.90 K(+9.9%) |
| Mar 2007 | - | $773.40 K(+11.6%) |
| Dec 2006 | - | $693.20 K(+45.9%) |
| Sept 2006 | - | $475.20 K(-68.1%) |
| June 2006 | $1.49 M(+2159.2%) | $1.49 M |
| June 2005 | $66.00 K | - |
FAQ
- What is NanoViricides annual total liabilities?
- What is the all time high annual total liabilities for NanoViricides?
- What is NanoViricides annual total liabilities year-on-year change?
- What is NanoViricides quarterly total liabilities?
- What is the all time high quarterly total liabilities for NanoViricides?
- What is NanoViricides quarterly total liabilities year-on-year change?
What is NanoViricides annual total liabilities?
The current annual total liabilities of NNVC is $1.36 M
What is the all time high annual total liabilities for NanoViricides?
NanoViricides all-time high annual total liabilities is $20.49 M
What is NanoViricides annual total liabilities year-on-year change?
Over the past year, NNVC annual total liabilities has changed by -$675.50 K (-33.21%)
What is NanoViricides quarterly total liabilities?
The current quarterly total liabilities of NNVC is $1.63 M
What is the all time high quarterly total liabilities for NanoViricides?
NanoViricides all-time high quarterly total liabilities is $20.49 M
What is NanoViricides quarterly total liabilities year-on-year change?
Over the past year, NNVC quarterly total liabilities has changed by -$815.60 K (-33.31%)